BLU-945 or BLU-701 as single agents versus their combination with osimertinib in EGFR L858R driven tumor models. (October 2022) - Tavera, L.; Campbell, J.; Dhande, A.; Dineen, T.; Iliou, M.; Rouskin-Faust, T.; Rozsahegyi, E.; Conti, C.